From: The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data
Metabolic syndrome components | All | Intervention | Control | p value (I vs. C) | ||||
---|---|---|---|---|---|---|---|---|
 | SA , (n = 18) | WE , (n = 62) | SA , (n = 11) | WE , (n = 31) | SA , (n = 7) | WE , (n = 31) | SA | WE |
Waist circumference(cm) | 101.6 ± 10.6 | 106.8 ± 10.8 | 101.6 ± 8.4 | 104.7 ± 10.8 | 101.6 ± 14.1 | 109.0 ± 10.5 | p = 0.989 | p = 0.118 |
Systolic BP (mmHg) | 135.2 ± 16.8 | 132.0 ± 15.1 | 137.6 ± 15.4 | 133.9 ± 12.4 | 131.3 ± 19.4 | 130.1 ± 17.5 | p = 0.452 | p = 0.326 |
Diastolic BP (mmHg) | 90.2 ± 9.7 | 84.8 ± 9.3 | 92.6 ± 8.1 | 83.1 ± 9.1 | 86.6 ± 11.5 | 86.4 ± 9.3 | p = 0.213 | p = 0.163 |
HDL cholesterol (mmol/l) | 1.20 [0.98 - 1.43] | 1.20 [1.08 - 1.43] | 1.10 [0.90 - 1.20] | 1.30 [1.10 - 1.80] | 1.30 [1.20 - 1.60] | 1.20 [1.10 - 1.30] | p = 0.082 | p = 0.015 |
Triglycerides (mmol/l) | 1.65 [1.20 - 1.95] | 1.60 [1.10 - 2.03] | 1.70 [1.20 - 2.10] | 1.40 [0.80 - 1.90] | 1.60 [1.40 - 1.90] | 1.70 [1.40 - 2.20] | p = 0.784 | p = 0.053 |
FPG (mmol/l) | 5.29 ± 0.60 | 5.20 ± 0.55 | 5.20 ± 0.49 | 5.25 ± 0.43 | 5.43 ± 0.77 | 5.15 ± 0.65 | p = 0.450 | p = 0.480 |
Proportion meeting IDF criteria for: | Â | Â | Â | Â | Â | Â | Â | Â |
   BP | 15 (83.3) | 56 (90.3) | 9 (81.8) | 28 (90.3) | 6 (85.7) | 28 (90.3) | p = 1.000 | p = 1.000 |
   FPG | 5 (27.8) | 17 (27.4) | 3 (27.3) | 9 (29.0) | 2 (28.6) | 8 (25.8) | p = 1.000 | p = 1.000 |
   HDL | 14 (77.8) | 56 (90.3) | 8 (72.7) | 27 (87.1) | 6 (85.7) | 29 (93.5) | p = 1.000 | p = 0.671 |
   Triglycerides | 13 (72.2) | 52 (83.9) | 7 (63.6) | 28 (90.3) | 6 (85.7) | 24 (77.4) | p = 0.596 | p = 0.300 |
Total no of IDF criteria met: | Â | Â | Â | Â | Â | Â | Â | Â |
   3 | 8 (44.4) | 17 (27.4) | 6 (54.5) | 7 (22.6) | 2 (28.6) | 10 (32.3) | p = 0.446 | p = 0.670 |
   4 | 9 (50.0) | 33 (53.2) | 5 (45.5) | 18 (58.1) | 4(57.1) | 15 (48.4) |  |  |
   5 | 1 (5.6) | 12 (19.4) | 0 (00.0) | 6 (19.4) | 1 (14.3) | 6 (19.4) |  |  |